Radiopharmaceutical diagnosis of Erdheim-Chester's disease

András Palotás, G. Bogáts, Máté Lázár, Miklós Papós, Keyvan Matin, L. Pávics

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Erdheim-Chester's disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.

Original languageEnglish
Pages (from-to)63-65
Number of pages3
JournalNuclear Medicine Communications
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Erdheim-Chester Disease
Radiopharmaceuticals
Histiocytosis
Nuclear Medicine
Radioisotopes
Lipids
Therapeutics

Keywords

  • Erdheim-Chester's disease
  • Histiocyte
  • Isotope
  • Nuclear medicine
  • Radiopharmaceutical
  • SPECT
  • Technetium-99m
  • Xantho-granuloma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Radiopharmaceutical diagnosis of Erdheim-Chester's disease. / Palotás, András; Bogáts, G.; Lázár, Máté; Papós, Miklós; Matin, Keyvan; Pávics, L.

In: Nuclear Medicine Communications, Vol. 28, No. 1, 01.2007, p. 63-65.

Research output: Contribution to journalArticle

Palotás, András ; Bogáts, G. ; Lázár, Máté ; Papós, Miklós ; Matin, Keyvan ; Pávics, L. / Radiopharmaceutical diagnosis of Erdheim-Chester's disease. In: Nuclear Medicine Communications. 2007 ; Vol. 28, No. 1. pp. 63-65.
@article{e13d12945d904f3cabd15baf1f9bae45,
title = "Radiopharmaceutical diagnosis of Erdheim-Chester's disease",
abstract = "Erdheim-Chester's disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.",
keywords = "Erdheim-Chester's disease, Histiocyte, Isotope, Nuclear medicine, Radiopharmaceutical, SPECT, Technetium-99m, Xantho-granuloma",
author = "Andr{\'a}s Palot{\'a}s and G. Bog{\'a}ts and M{\'a}t{\'e} L{\'a}z{\'a}r and Mikl{\'o}s Pap{\'o}s and Keyvan Matin and L. P{\'a}vics",
year = "2007",
month = "1",
doi = "10.1097/MNM.0b013e328013dcd3",
language = "English",
volume = "28",
pages = "63--65",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Radiopharmaceutical diagnosis of Erdheim-Chester's disease

AU - Palotás, András

AU - Bogáts, G.

AU - Lázár, Máté

AU - Papós, Miklós

AU - Matin, Keyvan

AU - Pávics, L.

PY - 2007/1

Y1 - 2007/1

N2 - Erdheim-Chester's disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.

AB - Erdheim-Chester's disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.

KW - Erdheim-Chester's disease

KW - Histiocyte

KW - Isotope

KW - Nuclear medicine

KW - Radiopharmaceutical

KW - SPECT

KW - Technetium-99m

KW - Xantho-granuloma

UR - http://www.scopus.com/inward/record.url?scp=33845637124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845637124&partnerID=8YFLogxK

U2 - 10.1097/MNM.0b013e328013dcd3

DO - 10.1097/MNM.0b013e328013dcd3

M3 - Article

VL - 28

SP - 63

EP - 65

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 1

ER -